AdvaMedDx supports the modernization of the regulatory framework for all clinical diagnostic tests to foster innovation, embrace scientific advances, and ensure swift access to accurate and reliable tests for all…
AdvaMedDx members represent the world’s leading diagnostics manufacturers alongside the next generation of companies developing innovative diagnostic tests and technologies in the U.S. and abroad.
AdvaMedDx members are medical technology firms that manufacture an in vitro diagnostic device or engage in research and development of such diagnostics.
AdvaMedDx collaborates with diagnostics associations across the country and around the world.
AdvaMedDx promotes innovation and expanded access to quality testing.
AdvaMed released a response to the Biden administration’s announcement today of its plan to expand COVID-19 testing in our nation’s K-8 schools.
AdvaMed and AdvaMedDx have prioritized supporting MedTech’s mobilization to the pandemic to protect patients and public health.
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed)—the world’s largest trade association for medical technology and diagnostics companies in the world—released the following statement from President and CEO Scott Whitaker on…
AdvaMed unveiled a newly repurposed platform to help device manufacturers locate and partner with thousands of component part manufacturers and sellers, should they need them during the COVID pandemic.
WASHINGTON, D.C. –New data from AdvaMed’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 200 million. A breakdown of the data shows that…